Correlation between p53 mutations and HPV in bilharzial bladder cancer

Urol Oncol. 2003 Sep-Oct;21(5):334-41. doi: 10.1016/s1078-1439(03)00014-0.

Abstract

Alterations of the p53 tumor suppressor gene are the most common genetic changes detected in human cancers as well as in papillary and invasive bladder cancer. Several studies have demonstrated an association between HPV infection and urological malignancies. In the present work, the p53 gene status was studied together with the frequency of HPV in 99 cases of Bilharzial bladder cancer [BBC] in Egypt and both were correlated to the clinicopathological features of the patients. SSCP and sequencing were used to screen the p53 gene for mutations at exons 4-10 and IHC was performed to detect protein overexpression. PCR was used for detection and typing of HPV-DNA in tumor samples. p53 mutations were detected in 33.3% of the studied cases whereas protein overexpression was detected in 35.6% of the cases. The highest concordance rate was observed in cases harboring mutations at exon 4 [87.5%]. Bilharzial infestation was obvious in 72.2% of the cases that showed mutations. Exon 8 showed the highest rate of mutation [32%] followed by exons 4 and 5 [22% each]. The commonest mutational event was G:C transversion [15/50] especially at CpG dinucleotides. A mutational hot spot was detected at exon 4, codons 72-73. HPV-DNA was detected in 48.97% of the cases the majority of which [64.6%] were of type 16. Significant correlation was found between p53 mutation and the pathological stage as well as p53 overexpression and tumor grade. Our results demonstrate that the mutational spectrum in BBC is different from that of bladder cancer in Western countries in many aspects and suggest an etiological role of HPV in this type of neoplasm. However, both HPV infection and p53 gene abnormalities may contribute to Bilharzial bladder carcinogenesis in an independent way.

MeSH terms

  • Adult
  • Aged
  • CpG Islands
  • DNA Mutational Analysis
  • Exons
  • Female
  • Genes, p53*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mutation*
  • Papillomaviridae / genetics*
  • Polymorphism, Single-Stranded Conformational
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / virology*